Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out
08:15pm, Wednesday, 24'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out
06:30pm, Tuesday, 23'rd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encourages Investors With Losses To Reach Out
04:15pm, Monday, 22'nd Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Verve Therapeutics, Inc. ("Verve Therapeutics") (NASDAQ:VERV) concerning possi
Verve Therapeutics Incorporated Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Connect
06:00pm, Friday, 19'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics, Inc. (VERV) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
06:15pm, Thursday, 18'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Verve Therapeutics, Inc. ("Verve Therapeutics") (NASDAQ:VERV) concerning possi
The Schall Law Firm Is Investigating Verve Therapeutics Incorporated And Encourages Investors With Losses To Reach Out
05:45pm, Thursday, 18'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Shareholder Rights Advocates at Levi & Korsinsky Investigate Verve Therapeutics, Inc. (VERV) Regarding Possible Securities Fraud Violations
03:30pm, Wednesday, 17'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Verve Therapeutics, Inc. ("Verve Therapeutics") (NASDAQ:VERV) concerning possi
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
NEW YORK, NY / ACCESSWIRE / July 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Verve Therapeutics, Inc. ("Verve Therapeutics") (NASDAQ:VERV) concerning possi
Verve Therapeutics Inc Is Being Probed By The Schall Law Firm Urging Investors With Losses To Contact
03:00pm, Tuesday, 16'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Did Verve Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate– VERV
04:05pm, Monday, 15'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Verve Therapeutics, Inc. ("Verve Therapeutics") (NASDAQ:VERV) concerning possi
Verve Therapeutics Inc Under Investigation By The Schall Law Firm Encouraging Investors With Losses To Reach Out
02:45pm, Monday, 15'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
Verve Therapeutics Inc Is Under Investigation By The Schall Law Firm Which Encourages Investors With Losses To Reach Out
05:00pm, Saturday, 13'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
The Schall Law Firm Is Probing Verve Therapeutics Inc And Urges Investors With Losses To Connect
06:00pm, Friday, 12'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutic
